As Bayer’s own report indicates, these cases are ongoing, and those who allege injuries from these products may be eligible to obtain compensation they deserve.
St. Louis, MO (PRWEB) March 28, 2013
Attorney John J. Driscoll today alerted users of the Yasmin/YAZ line of birth control products to Bayer HealthCare’s recently released 2012 Annual Report.
In the report, Bayer – the manufacturer of Yasmin, YAZ and related birth control products Ocella and Gianvi– states that it has thus far reached agreements, without admission of liability, to settle the claims of approximately 4,800 claimants in the U.S. alleging injuries from the products for a total amount of $1 billion.
Bayer says in the report that “[a]dditional lawsuits are anticipated.” According to Bayer, the company will be “only settling claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) after a case-specific analysis of medical records on a rolling basis.”
“If one believes they or a loved one has suffered deep vein thrombosis or pulmonary embolism as the result of taking Yasmin / YAZ or related birth control products, they should immediately contact an attorney who is familiar with these cases to have their situation thoroughly reviewed,” Driscoll said.
“As Bayer’s own report indicates, these cases are ongoing, and those who allege injuries from these products may be eligible to obtain compensation they deserve,” he added.
In the report, Bayer says that the number of lawsuits pending in the U.S. and served upon Bayer through February 12, 2013, stood at about 10,000. Additionally, about 1,200 asserted claims were pending and had not yet been filed in court, Bayer says.
According to Bayer, the claimants “allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin and/or YAZ or from the use of Ocella and/or Gianvi, generic versions of Yasmin and YAZ, respectively, marketed by Barr Laboratories, Inc.” in the U.S.
Bayer says the claimants have alleged that Bayer knew, or should have known, of the alleged risks of these products and should be held liable for having failed to disclose them or adequately warn users. The claims seek compensatory and punitive damages, Bayer notes.
Bayer says further that it expects additional lawsuits and “will continue to defend itself vigorously,” but that it has taken appropriate accounting measures for anticipated future settlements of claims alleging venous clot injuries.
As Driscoll explained, deep-vein thrombosis (DVT) is a blood clot that usually forms in the legs. It may cause pain, and it is more dangerous if it breaks free and travels through the bloodstream. Deep-vein thrombosis is the typical cause of pulmonary embolism, a potentially fatal blockage in the lungs. Blood clots can also cause heart attack or stroke.
The Driscoll Firm, P.C., is a nationally known personal injury firm that focuses on complex civil litigation pertaining to dangerous pharmaceuticals and defective medical products.
“Our firm is continuing to review injury claims from concerned birth control users and their families, and we will continue to stand by their side as they seek compensation,” Driscoll said.
About The Driscoll Firm, P.C.
The Driscoll Firm, P.C., is dedicated to fighting for the rights of people and families injured by the wrongful acts of individuals and companies. The firm is currently investigating national injury claims involving product liability, defective drugs, dangerous medical devices, medical malpractice, car accidents, premises liability, spinal cord injuries, birth injuries, cerebral palsy, brain injuries, Erb's palsy and other circumstances that have caused serious injury or death. The Driscoll Firm, P.C., is based at 211 N. Broadway, 40th Floor, St. Louis, MO, 63102, and serves clients nationwide. To learn more, call (800) 305-9800 or use the firm’s online contact form. All initial consultations are free and confidential.